The treatment of microscopic residual ovarian cancer with intraperitoneal interferon: a clinical and flow cytometric study.
Whelan
J S
JS
ICRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK.
van Dam
P A
PA
Shepherd
J H
JH
Slevin
M L
ML
D000231:Adenocarcinoma, Papillary / Q000473:pathology / Q000628:therapy*; D000328:Adult; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007263:Infusions, Parenteral; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000473:pathology / Q000628:therapy*; D010533:Peritoneal Lavage; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins